These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 35908908)
1. Prostaglandin D Fujimori K Biol Pharm Bull; 2022; 45(8):985-991. PubMed ID: 35908908 [TBL] [Abstract][Full Text] [Related]
2. Prostaglandins in the pathogenesis of kidney diseases. Li Y; Xia W; Zhao F; Wen Z; Zhang A; Huang S; Jia Z; Zhang Y Oncotarget; 2018 May; 9(41):26586-26602. PubMed ID: 29899878 [TBL] [Abstract][Full Text] [Related]
3. Pretreatment of cultured preadipocytes with arachidonic acid during the differentiation phase without a cAMP-elevating agent enhances fat storage after the maturation phase. Khan F; Syeda PK; Nartey MN; Rahman MS; Islam MS; Nishimura K; Jisaka M; Shono F; Yokota K Prostaglandins Other Lipid Mediat; 2016 Mar; 123():16-27. PubMed ID: 26928048 [TBL] [Abstract][Full Text] [Related]
4. 15-Deoxy-Δ(12,14)-prostaglandin J(2) interferes inducible synthesis of prostaglandins E(2) and F(2α) that suppress subsequent adipogenesis program in cultured preadipocytes. Chowdhury AA; Rahman MS; Nishimura K; Jisaka M; Nagaya T; Ishikawa T; Shono F; Yokota K Prostaglandins Other Lipid Mediat; 2011 Aug; 95(1-4):53-62. PubMed ID: 21699992 [TBL] [Abstract][Full Text] [Related]
5. COX-2 Deficiency Promotes White Adipogenesis via PGE2-Mediated Paracrine Mechanism and Exacerbates Diet-Induced Obesity. Wang C; Zhang X; Luo L; Luo Y; Wu D; Spilca D; Le Q; Yang X; Alvarez K; Hines WC; Yang XO; Liu M Cells; 2022 Jun; 11(11):. PubMed ID: 35681514 [TBL] [Abstract][Full Text] [Related]
6. Regulation of pancreatic β-cell function and mass dynamics by prostaglandin signaling. Carboneau BA; Breyer RM; Gannon M J Cell Commun Signal; 2017 Jun; 11(2):105-116. PubMed ID: 28132118 [TBL] [Abstract][Full Text] [Related]
7. Prostaglandin D2 and its analog, 11d-11m-PGD2, added during the differentiation phase contribute to adipogenic program inhibition in 3T3-L1 cells. Nartey MNN; Jisaka M; Syeda PK; Nishimura K; Shimizu H; Yokota K Biosci Biotechnol Biochem; 2022 Apr; 86(5):628-634. PubMed ID: 35266506 [TBL] [Abstract][Full Text] [Related]
8. Pathophysiological Roles of Cyclooxygenases and Prostaglandins in the Central Nervous System. Yagami T; Koma H; Yamamoto Y Mol Neurobiol; 2016 Sep; 53(7):4754-71. PubMed ID: 26328537 [TBL] [Abstract][Full Text] [Related]
9. Prostacyclin: A major prostaglandin in the regulation of adipose tissue development. Rahman MS J Cell Physiol; 2019 Apr; 234(4):3254-3262. PubMed ID: 30431153 [TBL] [Abstract][Full Text] [Related]
10. Aldose reductases influence prostaglandin F2α levels and adipocyte differentiation in male mouse and human species. Pastel E; Pointud JC; Loubeau G; Dani C; Slim K; Martin G; Volat F; Sahut-Barnola I; Val P; Martinez A; Lefrançois-Martinez AM Endocrinology; 2015 May; 156(5):1671-84. PubMed ID: 25730106 [TBL] [Abstract][Full Text] [Related]
11. Prostaglandin F2α inhibits adipogenesis via an autocrine-mediated interleukin-11/glycoprotein 130/STAT1-dependent signaling cascade. Annamalai D; Clipstone NA J Cell Biochem; 2014 Jul; 115(7):1308-21. PubMed ID: 24519625 [TBL] [Abstract][Full Text] [Related]
12. Coordinate functional regulation between microsomal prostaglandin E synthase-1 (mPGES-1) and peroxisome proliferator-activated receptor γ (PPARγ) in the conversion of white-to-brown adipocytes. García-Alonso V; López-Vicario C; Titos E; Morán-Salvador E; González-Périz A; Rius B; Párrizas M; Werz O; Arroyo V; Clària J J Biol Chem; 2013 Sep; 288(39):28230-42. PubMed ID: 23943621 [TBL] [Abstract][Full Text] [Related]
13. Activation of the prostanoid FP receptor inhibits adipogenesis leading to deepening of the upper eyelid sulcus in prostaglandin-associated periorbitopathy. Taketani Y; Yamagishi R; Fujishiro T; Igarashi M; Sakata R; Aihara M Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1269-76. PubMed ID: 24508785 [TBL] [Abstract][Full Text] [Related]
14. Comparison of pro-adipogenic effects between prostaglandin (PG) D Rahman MS; Syeda PK; Nartey MNN; Chowdhury MMI; Shimizu H; Nishimura K; Jisaka M; Shono F; Yokota K Prostaglandins Other Lipid Mediat; 2018 Nov; 139():71-79. PubMed ID: 30393164 [TBL] [Abstract][Full Text] [Related]
15. Prostaglandins as PPARγ Modulators in Adipogenesis. Fujimori K PPAR Res; 2012; 2012():527607. PubMed ID: 23319937 [TBL] [Abstract][Full Text] [Related]
16. Differentiation-dependent regulation of the cyclooxygenase cascade during adipogenesis suggests a complex role for prostaglandins. Xie Y; Kang X; Ackerman WE; Belury MA; Koster C; Rovin BH; Landon MB; Kniss DA Diabetes Obes Metab; 2006 Jan; 8(1):83-93. PubMed ID: 16367886 [TBL] [Abstract][Full Text] [Related]
17. Arachidonic Acid Added during the Differentiation Phase of 3T3-L1 Cells Exerts Anti-Adipogenic Effect by Reducing the Effects of Pro-Adipogenic Prostaglandins. Nartey MNN; Jisaka M; Syeda PK; Nishimura K; Shimizu H; Yokota K Life (Basel); 2023 Jan; 13(2):. PubMed ID: 36836723 [TBL] [Abstract][Full Text] [Related]
18. Depot-specific prostaglandin synthesis in human adipose tissue: a novel possible mechanism of adipogenesis. Quinkler M; Bujalska IJ; Tomlinson JW; Smith DM; Stewart PM Gene; 2006 Oct; 380(2):137-43. PubMed ID: 16842938 [TBL] [Abstract][Full Text] [Related]